IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Northpond Ventures, LLC

Q2 2024 Holdings

Filed 2024-08-14 | 4 holdings | $55.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Kyverna Therapeutics Inc(KYTX)COM501976104$24.4M3,255,42644.2%
Vigil Neuroscience Inc(VIGL)COM92673K108$16.9M4,214,49830.5%
Candel Therapeutics Inc(CADL)COM137404109$12.0M1,935,21521.7%
Telesis BIO Inc(TBIO)COM NEW192003200$2.0M546,8973.6%